Brain switch may curb liver sugar in diabetes
NCT ID NCT03540758
First seen Apr 29, 2026 · Last updated May 20, 2026 · Updated 2 times
Summary
This study tests whether a drug called diazoxide can lower the amount of sugar the liver makes by activating control centers in the brain. It includes 100 people—some with type 2 diabetes and some healthy—to see how this affects blood sugar levels. The goal is to better understand how the brain and liver work together in diabetes, not to provide a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Albert Einstein College of Medicine
RECRUITINGThe Bronx, New York, 10461, United States
Contact
Conditions
Explore the condition pages connected to this study.